ALDH1A2 and neoplasm: ALDH1A2 has previously been identified as a candidate tumor suppressor (Kim et al., 2005) and its downregulation accelerates an epithelial-to-mesenchymal transition (Seidensaal et al., 2015), an important component of CTB invasion.